News and Insights
Case Study: Differentiating a New MOA in a Crowded Therapeutic Area
A global pharmaceutical company acquired a newly approved product with a unique MOA and needed to prove its economic and clinical value to decision makers that were generally satisfied with available, cheaper alternatives. Numerof conducted a thorough assessment to identify new claims and supporting data that could be used to influence purchase decisions.Read More
Thank you for your interest in our content. Registering allows you to access a wide range of informative articles, briefs, and whitepapers throughout the site.